Fluorescent In Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies Reply

被引：4
|
作者：
Sauter, Guido [1 ]
Lee, James A. [2 ]
Slamon, Dennis J. [3 ]
Press, Michael F. [4 ,5 ]
机构：
[1] Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany
[2] Altarum Inst, Ann Arbor, MI USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Keck Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90095 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 05期
关键词：
COST-EFFECTIVENESS ANALYSIS; RECEPTOR; 2; ASSESSMENT; GENE AMPLIFICATION; IMMUNOHISTOCHEMICAL ASSAY; FISH; TRASTUZUMAB; CONCORDANCE; CARCINOMAS; EXPRESSION; HERCEPTEST;
D O I：
10.1200/JCO.2009.25.3930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E85 / E88
页数：4
相关论文
共 50 条
  • [41] Flourescence in situ hybridization (FISH) as the primary methodology for the assessment of HER2 status in adenocarcinoma of the breast:: a single institution experience
    Tubbs, R
    Hicks, DG
    Downs-Kelly, E
    Pettay, J
    Hartke, M
    Myles, J
    Budd, GT
    Crowe, JP
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S256 - S257
  • [42] "Non-Classical" HER2 Fluorescent in Situ Hybridization Categories in Breast Cancer with Clinical-Pathologic Correlation
    Yang, Ellen
    Wu, Jessie
    Armstrong, Susan
    Mrkonjic, Miralem
    Turashvili, Gulisa
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 209 - 210
  • [43] Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 status in adenocarcinoma of the breast - A single institution experience
    Tubbs, Raymond R.
    Hicks, David G.
    Cook, James
    Downs-Kelly, Erinn
    Pettay, James
    Hartke, Mary Beth
    Hood, LaShonda
    Neelon, Rosemary
    Myles, Jonathan
    Budd, George Thomas
    Moore, Halle C.
    Andresen, Steve
    Crowe, Joseph P.
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2007, 16 (04) : 207 - 210
  • [44] Comparison of HER2 status determination methods in HER2 (2+) patients: Manual fluorescent in situ hybridization (FISH) vs. dual silver enhanced in situ hybridization (SISH)
    Pehlivanoglu, Burcin
    Serin, Gurdeniz
    Yeniay, Levent
    Zekioglu, Osman
    Gokmen, Erhan
    Ozdemir, Necmettin
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 31 : 36 - 40
  • [45] Droplet digital polymerase chain reaction offers an improvisation over conventional immunohistochemistry and fluorescent in situ hybridization for ascertaining Her2 status of breast cancer
    Suryavanshi, Moushumi
    Jaipuria, Jiten
    Mehta, Anurag
    Kumar, Dushyant
    Panigrahi, Manoj Kumar
    Verma, Haristuti
    Saifi, Mumtaz
    Sharma, Sanjeev
    Tandon, Simran
    Doval, Dinesh Chandra
    Das, Bhudev C.
    SOUTH ASIAN JOURNAL OF CANCER, 2019, 8 (04) : 203 - +
  • [46] Detection of ERBB2 and CEN17 signals in fluorescent in situ hybridization and dual in situ hybridization for guiding breast cancer HER2 target therapy
    Wang, Ching-Wei
    Khalil, Muhammad-Adil
    Lin, Yi-Jia
    Lee, Yu-Ching
    Chao, Tai-Kuang
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2023, 141
  • [47] Efficacy of HER2 inhibitors in metastatic breast cancer by discordance in HER2 amplification status between primary and metastatic breast cancer
    Van Raemdonck, E.
    Berteloot, P.
    Laenen, A.
    Han, S.
    Van Nieuwenhuysen, E.
    Salihi, R.
    Concin, N.
    Vergote, I.
    Floris, G.
    Wildiers, H.
    Punie, K.
    Neven, P.
    CANCER RESEARCH, 2019, 79 (04)
  • [48] Comparison of fluorescence in situ hybridization and dual color chromogenic in situ hybridization for the assessment of HER2 status on core-needle breast cancer biopsies
    Suarez-Gauthier, A.
    Garcia-Garcia, E.
    Conde, E.
    Munoz, A.
    Torres, M.
    Miro, C.
    Garcia-Estevez, L.
    Lopez-Rios, F.
    CANCER RESEARCH, 2009, 69 (02) : 209S - 209S
  • [49] Rapid Fluorescence in Situ Hybridization (FISH) for HER2 Assessment in Breast and Gastroesophageal Cancer
    Dokus, B. J.
    Allen, S. F.
    Steinmetz, H. B.
    Marotti, J. D.
    Tsongalis, G. J.
    Tafe, L. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 908 - 908
  • [50] Dual-Color In Situ Hybridization (Dual ISH) for Evaluation of HER2/Neu (HER2) Amplification in Breast Cancer
    Astvatsaturyan, K.
    Bose, S.
    MODERN PATHOLOGY, 2013, 26 : 28A - 28A
12345